Literature DB >> 10361258

The IGF axis and programmed cell death.

A J Butt1, S M Firth, R C Baxter.   

Abstract

Insulin-like growth factors (IGF) are mitogenic peptides that have been implicated as positive regulators of cellular proliferation. In recent years, several studies have suggested an additional role for the IGF axis in the regulation of apoptosis. Signalling through the IGF receptor has been shown to have a potent survival function and protect cells from a variety of apoptotic stimuli. The actions of IGF are regulated by a family of high-affinity IGF binding proteins (IGFBP), which sequester the IGF from the IGF receptor. However, there is some evidence that one of these binding proteins, IGFBP-3, may have its own pro-apoptotic effects that are independent of its ability to modulate IGF bioavailability. In addition, it has been suggested that the tumour suppressor p53, a crucial mediator of apoptosis in response to cellular stress, may elicit several of its apoptotic effects through manipulation of components of the IGF axis. This review summarizes what is currently known about the role of the IGF system in the regulation of apoptosis, highlighting its implications in the context of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361258     DOI: 10.1046/j.1440-1711.1999.00822.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  35 in total

1.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.

Authors:  Hsi-Hsien Hsu; Li-Hao Cheng; Tsung-Jung Ho; Wei-Wen Kuo; Yueh-Min Lin; Ming-Cheng Chen; Nien-Hung Lee; Fuu-Jen Tsai; Kun-Hsi Tsai; Chih-Yang Huang
Journal:  Tumour Biol       Date:  2013-08-30

3.  Expression profiling of p53-target genes in copper-mediated neuronal apoptosis.

Authors:  Jacob W Vanlandingham; Nadine M Tassabehji; Rikki C Somers; Cathy W Levenson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Signaling mechanisms involved in the response to genotoxic stress and regulating lifespan.

Authors:  Laura J Niedernhofer; Paul D Robbins
Journal:  Int J Biochem Cell Biol       Date:  2007-10-13       Impact factor: 5.085

5.  C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.

Authors:  Madeleine Grooteclaes; Quinn Deveraux; Jeffrey Hildebrand; Qinghong Zhang; Richard H Goodman; Steven M Frisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

Review 6.  Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.

Authors:  R C Baxter
Journal:  Mol Pathol       Date:  2001-06

7.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells.

Authors:  Aleksandar Sokolović; Milka Sokolović; Willem Boers; Ronald Pj Oude Elferink; Piter J Bosma
Journal:  Fibrogenesis Tissue Repair       Date:  2010-02-17

9.  Maintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3.

Authors:  Jian Chen; Jun Li; Fei Chu Lim; Qi Wu; Daniel C Douek; Donald K Scott; Eric Ravussin; Hui-Chen Hsu; S Michal Jazwinski; John D Mountz
Journal:  Mech Ageing Dev       Date:  2009-11-24       Impact factor: 5.432

10.  IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.

Authors:  Munenori Takaoka; Seok-Hyun Kim; Takaomi Okawa; Carmen Z Michaylira; Douglas B Stairs; Cameron N Johnstone; Claudia D Andl; Ben Rhoades; James J Lee; Andres J P Klein-Szanto; Wafik S El-Deiry; Hiroshi Nakagawa
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.